Seller record · Telehealth service
Fella Health
Fails 2 of 8 criteria. S5, analytical documentation: No certificate of analysis, chromatogram or lot document is linked anywhere on the site, and the treatments page asserts quality without naming a laboratory, a figure or a method. 1 more criterion also fails; see the table below.
At a glance
Fella HealthTelehealth service
- Price
- Not printed before a consultation or sign-up
- Sells
- compounded GLP-1 plans, compounded microdose plans, enclomiphene, and 3 more
- FDA letters
- None on file
Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.
A telehealth weight-loss and hormone program marketed to men, with clinical services delivered by a named medical group. It names two partner pharmacies with street addresses, and it prints no figure for its GLP-1 program.
Operating entity Aios Inc.
Dispositions
| Code | Criterion | Disposition | Where it appears |
|---|---|---|---|
| S1 | Prescriber requirement | PASS | Fella Health's treatments page |
| S2 | Prescription gating | PASS | Fella Health's promo quiz page |
| S3 | Pharmacy identification | PASS | Fella Health's FAQ |
| S4 | Compounding disclosure | PASS | Fella Health's treatments page |
| S5 | Analytical documentation | FAIL | Fella Health's treatments page |
| S6 | Business address | PASS | Fella Health's website |
| S7 | Price disclosure | FAIL | Fella Health's treatments page |
| S8 | Enforcement status | PASS | FDA warning-letter index |
Evidence, criterion by criterion
The evidence behind each disposition in the table above, where it appears, and its date.
Products shown on the seller's own pages at the recorded date: compounded GLP-1 plans, compounded microdose plans, enclomiphene, metformin, rapamycin, NAD+.
Other sellers of the same products
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.